Skip to main content
Download PDF

Knockout of caspase-7 gene improves the expression of recombinant protein in CHO cell line through the cell cycle arrest in G2/M phase

Biological Research volume 55, Article number: 2 (2022) Cite this article

Abstract

Background

Chinese hamster ovary cell line has been used routinely as a bioproduction factory of numerous biopharmaceuticals. So far, various engineering strategies have been recruited to improve the production efficiency of this cell line such as apoptosis engineering. Previously, it is reported that the caspase-7 deficiency in CHO cells reduces the cell proliferation rate. But the effect of this reduction on the CHO cell productivity remained unclear. Hence, in the study at hand the effect of caspase-7 deficiency was assessed on the cell growth, viability and protein expression. In addition, the enzymatic activity of caspase-3 was investigated in the absence of caspase-7.

Results

Findings showed that in the absence of caspase-7, both cell growth and cell viability were decreased. Cell cycle analysis illustrated that the CHO knockout (CHO-KO) cells experienced a cell cycle arrest in G2/M phase. This cell cycle arrest resulted in a 1.7-fold increase in the expression of luciferase in CHO-KO cells compared to parenteral cells. Furthermore, in the apoptotic situation the enzymatic activity of caspase-3 in CHO-KO cells was approximately 3 times more than CHO-K1 cells.

Conclusions

These findings represented that; however, caspase-7 deficiency reduces the cell proliferation rate but the resulted cell cycle arrest leads to the enhancement of recombinant protein expression. Moreover, increasing in the caspase-3 enzymatic activity compensates the absence of caspase-7 in the caspase cascade of apoptosis.

Background

CHO cell line is the most common mammalian expression system vastly used for the production of therapeutics [1, 2]. This host cell is the cellular factory of about one third of all biopharmaceutical products approved by FDA since 1982 [3]. Therefore, enhancing the yield of this expression system is greatly in consideration. Responding market demands for biologicals, CHO cells must be cultured in huge densities in large bioreactors. Culture in huge density leads to environmental perturbations and cell stress due to the limitation of oxygen and nutrients as well as the accumulation of toxic metabolites. Intensive and continuous stress induces cell death employing one of these two pathways including apoptosis (programmed cell death) and passive cell death called necrosis [4]. Almost all apoptosis mediating death pathways lead to the activation of specific downstream caspase proteins. Caspases are classified into two classes composed of executor caspases (3, 6 and 7) and initiator caspases (8, 9, 10 and 12). The activation of caspase-3 and 7 by initiator caspases allows the cleavage of various substrates and triggers morphological and biochemical characteristics of apoptosis such as the release of phosphatidylserine, condensation of nuclei and fragmentation of genomic DNA [5]. Recent reports showed that caspase-7 plays a role in ROS production and cell detachment [6]. In addition to apoptosis, caspase-7 has also non-apoptotic roles, for instance in cell cycle progression. To this end, it has been reported that the proteolytic activity of caspases affects the cell cycle proteins as their substrates [7]. Caspase-mediated cleavage of cell cycle proteins causes the activation and/or translocation of these proteins such as retinoblastoma (Rb) which is cleaved by caspase-3 and -7 [8]. Following this cleavage, truncated Rb joins cyclin D3 and reduces E2F1 transcriptional activity [9]. In our recent research, caspase-7 deficient CHO cells were generated by using CRISPR/Cas9 system [10, 11]. HITI technology was employed for silencing caspase-7 by simultaneous knockout/knock-in which facilitated the selection of knocked out clones [12]. Further, results of this study demonstrated that caspase-7 deficiency had an adverse effect on cell cycle progression resulting in the reduction of cell proliferation [13]. However, the mechanism of this event still remains unclear. Accordingly, in the study at hand, we aimed to identify the mechanisms by which caspase-7 affects cell growth, cell viability and cell cycle progression and investigate the effect of caspase-7 silencing on the expression yield of recombinant protein.

Results

Caspase-7 deficiency reduces cell growth and cell viability

Cell doubling time (T2) is an important parameter used for illustrating the dynamics of cell clone development which shows the average time between cell divisions. T2 is measured typically by the observation of changes in the cell density during the time [14]. Growth characteristics of native CHO-K1 and CHO-KO cells are shown in Fig. 1a, b. The growth rate of these two cell lines was comparable for 4 days, with average doubling times of 20 h for the native CHO-K1 cell line and 26 h for the CHO-KO cells.

Fig. 1
figure 1

Growth dynamics and cell viability: a Comparison of cell viability between CHO-K1 and CHO-KO cells during 24, 48 and 96 h. b Comparison of cell counting between CHO-K1and CHO-KO cells during 24, 48, 72 and 96 h. Results represent the average of three analyses (n = 5), and error bars represent the standard deviation (p < 0.05). (*:> 0.05, **:> 0.01, ***:> 0.001, ****:> 0.0001)

Full size image

Caspase-7 silencing leads to cell cycle arrest in G2/M phase

Proliferation in mammalian cells is regulated by a group of checkpoints which together form the cell cycle. These checkpoints control the events needed for accurate cell division and prevent the occurrence of each step prior to the completion of preceding steps [15]. Flow cytometric cell cycle analysis on asynchronous cells showed that compared with the native CHO-K1 cell line, the CHO-KO cell line had a 10% higher proportion of cells in the G2/M phase and a 3% higher proportion of cells in the G0/G1 phase (Fig. 2).

Fig. 2
figure 2

The effect of CASP7 knockout on cell cycle progression by FACS‐based, propidium iodide cell cycle analysis. a CHO-K1 cells, b CHO-KO cells. c Percentages of cells in the G1, S, or G2/M in asynchronous cultures calculated using FlowJo software. Results represent the average of three analyses (n = 3), and error bars represent the standard deviation (p < 0.05). (*:> 0.05, **:> 0.01, ***:> 0.001, ****:> 0.0001)

Full size image

Caspase-7 silencing increases the expression of luciferase and JRed in the CHO-KO cell line

The effect of caspase-7 silencing on the constitutive expression of recombinant luciferase is shown in Fig. 3. Compared with the native CHO-K1 cell line, the caspase-7 deficient clone represented an average of 1.7-fold increase in specific luciferase expression. In addition, the expression of JRed was increased by up to 1.5-fold in CHO-KO cells compared to CHO-K1 cells (Fig. 4).

Fig. 3
figure 3

luciferase expression assay; Graph is representative of three separate production experiments during 24, 72 and 120 h after transfection, and error bars represent the standard deviation (p < 0.05). In this assay each experiment was repeated 3 times and n = 3, (*: > 0.05, **: > 0.01, ***: > 0.001, ****: > 0.0001)

Full size image
Fig. 4
figure 4

JRed expression assay; a The histogram of JRed expression in CHO-KO and CHO-K1 cells after 120 h of transfection, b the chart containing the percentage of JRed expression in CHO-KO and CHO-K1 cells after 24, 72 and 120 h after transfection. Findings represented the analysis of 3 experiments and n was 3. Error bars represent the standard deviation (p < 0.05). (*:> 0.05, **:> 0.01, ***:> 0.001, ****:> 0.0001)

Full size image

Caspase-3 compensates the absence of caspase -7

Caspase-3 is a critical player of typical morphological and biochemical changes of cells undergoing apoptosis such as nuclear fragmentation. Findings of this assay showed that caspase-3 activity had increased by up to threefold in CHO-KO cells undergoing apoptosis mediated by NaBu in comparison with CHO-K1 cells (Fig. 5). This result represented that caspase-3 had compensated for the absence of caspase-7 in the progression of apoptosis.

Fig. 5
figure 5

Caspase 3 activity assay; this chart represents the caspase 3 activity in lysate of CHO-KO and CHO-K1 cells undergoing the apoptosis mediated by NaBu (11 mM). Findings display the average of three analyses (n = 3), and error bars represent the standard deviation (p < 0.05). (*:> 0.05, **:> 0.01, ***:> 0.001, ****:> 0.0001)

Full size image

Discussion

Numerous approaches and strategies have been used for large scale and cost-effective production of biopharmaceuticals in CHO cell line to increase the production of high-quality therapeutics. These techniques include the improvement of culture media and additive supplements [16], selection of high-producing clones [17], optimization of transcriptional activity through vector engineering [18], and gene overexpression or silencing [19] using cell line engineering [1, 20]. Apoptosis engineering by overcoming the cell death and enhancing the time integral of the viable cell concentration has been one of the important strategies which increases the product yields [4].

Apoptosis has been extensively investigated in CHO cells using strategies such as slowing down or inhibiting apoptosis for prolonged culture longevity. Along with caspases as mediators of apoptosis, the Bcl-2 family including pro- and anti-apoptotic members plays a critical role in the fate of apoptosis by adjusting the release of cytochrome c in the mitochondrial membrane [21]. Hence, numerous studies have primarily been investigating the overexpression of anti-apoptotic members of the Bcl-2 family and the down-regulation of caspases to impede or delay apoptosis [22].

Caspases-3 and 7 have been identified as major mediators of apoptosis progression [2]. As well as caspase-3, caspase-7 is an executioner caspase involved in cleaving downstream substrates such as PARP [23]. During apoptosis, caspase-7 is activated by initiator caspases via proteolytic activity at Asp23, Asp198, and Asp206, which leads to the production of the mature caspase-7 subunits [5]. Like caspases-2 and -3, caspase-7 also cleaves substrates using DEVD sequences as recognition sites [24].

It is reported that Co-down-regulation of both caspase-3 and caspase-7 by using siRNA in CHO cells enhanced the cell viability and increased culture longevity [25]. But we reported that CRISPR system mediated caspase-7 silencing in CHO cell leading to a reduction in cell proliferation. It seems that cell cycle arrest is the cause of decreasing cell proliferation which is due to the non-apoptotic roles of caspase-7. Findings of this research represented that the doubling time of CHO-KO had increased 6 h which was related to cell cycle arrest in G2/M phase. It is worth mentioning that controlling cell proliferation by manipulating cell cycle in recombinant cell lines is in the context of biotechnology and leads to an increase in the expression of heterologous proteins. Growth arrest can be induced in both G1/G0 and G2/M checkpoints but arrest induction is more common in G1/S phase [26].

In line with our findings, a series of Hashimoto and his colleagues’ data displayed that caspase-7 involved in the cell cycle regulation at mitotic phase. They reported that caspase-3, caspase-7, caspase-8 and caspase-9 were activated in the cells in an apoptosis-independent manner. In addition, it was identified that target proteins of caspases during apoptosis have function in cell cycle development. For instance, p21 and p27, cyclin E and Rb (Cdk inhibitors) regulate the progression of cell cycle from G1 to S phases. Moreover, it seems that Bub1, Scc1/Rad 21, BubR1, INCENP and CENP-C are contributed to M phase progression [27,28,29,30]. These proteins are necessary for cell cycle checkpoints; hence the dysfunction of these proteins may lead to tumorigenesis [31,32,33]. Activation of caspases in cancer cells may cause the loss of cell cycle checkpoints and increase the proliferation of these tumor cells. As cell cycle assay using PI staining does not differentiate in G2 and M cell cycle phases and also the difference between the essence of cancer and normal cells, findings of our study elucidate the role of caspase 7 in targeting proteins required for G2/M progression.

Results of this study showed that the expression of luciferase in CHO-KO cells was 1.7 times more than parenteral CHO-K1 cells. This event may be due to the arrest that occurred in G2/M phase of cell cycle. The higher JRed expression (1.5-fold) in CHO-KO cells compared to CHO-K1 cells also confirmed the primary findings. In line with this evidence, Abaandou et al. reported that the caspase 8‐associated protein 2 (CASP8AP2) gene silencing improved recombinant protein expression in HEK293 cells by inducing cell cycle arrest in G0/G1 checkpoint [34]. They demonstrated that silencing CASP8AP2 lead to the enhancement of luciferase and SEAP production by up to 7- and 2.5-fold respectively. This event may be due to the cell cycle arrest in G0/G1 checkpoint. As in G0/G1 phase cells represent higher metabolic activity, inducing growth arrest at this phase is a known strategy for enhancing productivity of mammalian cell lines [35,36,37]. In this phase, the expression of genes involved in ribosome biosynthesis and protein translation increases [38,39,40]. Therefore, the difference between the protein expression in CASP8AP2 knockout HEK cells and CASP7 deficient CHO cells may associate with the difference in the phases of cell cycle arrest.

Caspase-3 and caspase-7 are responsible for the majority of cleavages that occur during apoptosis [41]. It was believed that in apoptosis the cleavage-specificity profiles of caspase-3 and caspase-7 were redundant [42, 43]. However, recent studies have reported that caspase-3 and caspase-7 must have definite functions. This data relies on the findings that showed mice deficient in these caspases represented different phenotypes [23, 44]. It has been suggested that caspase-3 is the major mediator of apoptosis, while caspase-7 plays other roles [23]. The result of this study revealed the dominancy of caspase-3 in apoptosis, because in the absence of caspase-7 the enzymatic activity of caspase-3 increased which led to apoptosis progression and cell death. This finding is confirmed by other studies reporting that caspase 3 and caspase 7 are similar structurally and caspase-3 might compensate for the lack of caspase-7 [45, 46].

Conclusions

Taken together, results of this study suggests that the caspase-7 deficiency may lead to the increase in recombinant protein expression. Although this enhancement is not significant due to the reduction of cell proliferation, it may be helpful in small scale protein production. As fundamental research, finding of this study clears the dominant role of caspase-3 in progression of apoptosis in the lack of caspase-7 in CHO cells; which approved the previous data in this case.

Methods

Cells and culture conditions

CHO-K1 and CHO-KO cells were maintained in RPMI medium supplemented with 10% fetal bovine serum as described previously [47]. Cultures were incubated at 37 °C in a 5% CO2 atmosphere. Pen/Strep stock (1 mg/mL) was prepared and diluted into the culture medium to a final concentration of 10 μg/mL.

Cell doubling time and viability assay

CHO-KO and native CHO-K1 cells were plated in 96-well plates with a concentration of 5 × 103 per well in quintuplicate. Cells were incubated for 24, 48, 72 and 96 h [34] and after that doubling time of cells was identified by using cell counter. For cell viability assay the medium from each well was entirely removed and replaced with 100 µL of fresh serum-free culture medium containing 5 mg/mL MTT solution. After 4 h of incubation, media was replaced by 100 µL of DMSO and mixing thoroughly by using an orbit plate shaker. Then, plates were incubated for an additional 10 min and the absorbance was read at 545 and 630 nm reference wavelengths.

Flow cytometry analysis of the cell cycle

CHO-KO and native CHO-K1 cells were seeded in the 6-well plate by the concentration of 5 × 105 cells/well. After 28 h [34], cells were fixed in 70% ethanol [48], and DNA was stained using PI in the presence of DNase-free RNase A (40 mg/mL) for 30 min at 37 °C in the dark circumstance. Cell cycle analysis was performed using flow cytometry (Beckman Coulter FC500; Beckman Coulter) according to the manufacturer’s instructions.

Luciferase activity assay

Approximately 3 × 104 CHO-KO and native CHO-K1 cells were seeded and cultivated for 24 h in each well of a 96-well plate. Then 100 ng psi-check2 vector was transfected into the CHO cells in triplicate. 24, 72 and 120 h after transfection [34], cells were lysed utilizing passive lysis buffer containing Tris/phosphate 25 mM, Triton X100 1%, Glycerol 10%, and DTT 2 mM. After that the firefly intensity was measured using GloMax Multi-detection system (Promega) in a luminometer at the excitation wave length of 520 nm.

JRed expression assay

Approximately 3 × 104 CHO-KO and native CHO-K1 cells were seeded and cultivated for 24 h in each well of a 24-well plate. Then 100 ng of pLEX-JRed vector was transfected into the CHO cells in triplicate. 24, 72 and 120 h after transfection [34], the expression of JRed was assessed using flow cytometry (Beckman Coulter FC500; Beckman Coulter).

Caspase-3 activity assay

A caspase-3 activity fluorometric assay (N-acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin; Sigma, A1086) was used according to the manufacturer’s protocol. CHO-KO and native CHO-K1 cells were seeded at a density of 3 × 104 cells/well in 24-well plates in triplicate. After 24 h, cells were exposed to NaBu (11 mM) for 48 h [13] and then they were lysed using lysis buffer (Tris/phosphate 25 mM, Triton X100 1%, Glycerol 10%, DTT 2 mM). Samples containing equal amounts of total protein were incubated with the DEVD substrate at 37 °C for 1 h. The samples were then evaluated by measuring light absorbance at an excitation wavelength of 380 nm and emission wavelength of 440 nm in an automatic microplate reader.

Statistical analysis

All assays were performed in triplicates and repeated. Statistical analyses of the data were done using GraphPad Prism 6.0, and the data were represented as mean ± S.E. Calculations of the level of significance (p) were done by Mann–Whitney U test, A p value less than 0.05 (p < 0.05) was considered statistically significant.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CHO:

Chinese hamster ovary

CRISPR:

Clustered regularly interspaced short palindromic repeats

Cas:

CRISPR-associated protein

HITI:

Homology independent targeted integration

EGFP:

Enhanced green fluorescent protein

NaBu:

Sodium butyrate

References

  1. Grav LM, Lee JS, Gerling S, Kallehauge TB, Hansen AH, Kol S, et al. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment. Biotechnol J. 2015;10(9):1446–56.

    Article  CAS  PubMed  Google Scholar 

  2. Safari F, Farajnia S, Ghasemi Y, Zarghami N, Barekati MM. Multiplex genome editing in chinese hamster ovary cell line using all-in-one and HITI CRISPR technology. Adv Pharm Bull. 2021;11(2):343–50.

    CAS  PubMed  Google Scholar 

  3. Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32(10):992–1000.

    Article  CAS  PubMed  Google Scholar 

  4. Hwang SO, Lee GM. Nutrient deprivation induces autophagy as well as apoptosis in Chinese hamster ovary cell culture. Biotechnol Bioeng. 2008;99(3):678–85.

    Article  CAS  PubMed  Google Scholar 

  5. Lamkanfi M, Kanneganti TD. Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol. 2010;42(1):21–4.

    Article  CAS  PubMed  Google Scholar 

  6. Krampe B, Al-Rubeai M. Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies. Cytotechnology. 2010;62(3):175–88.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Connolly P, Garcia-Carpio I, Villunger A. Cell-cycle cross talk with caspases and their substrates. Cold Spring Harbor Perspect Biol. 2020;12(6):a036475.

    Article  CAS  Google Scholar 

  8. Fattman CL, Delach SM, Dou QP, Johnson DE. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene. 2001;20(23):2918–26.

    Article  CAS  PubMed  Google Scholar 

  9. Jänicke RU, Walker PA, Lin XY, Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 1996;15(24):6969–78.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Safari F, Farajnia S, Arya M, Zarredar H, Nasrolahi A. CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018;40(3):201–11.

    Article  CAS  PubMed  Google Scholar 

  11. Safari F, Afarid M, Rastegari B, Borhani-Haghighi A, Barekati-Mowahed M, Behzad-Behbahani A. CRISPR systems: novel approaches for detection and combating COVID-19. Virus Res. 2021;294:198282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zare K, Shademan M, Ghahramani Seno MM, Dehghani H. CRISPR/Cas9 knockout strategies to ablate CCAT1 lncRNA gene in cancer cells. Biol Proced Online. 2018;20:21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Safari F, Farajnia S, Behzad Behbahani A, Zarredar H, Barekati-Mowahed M, Dehghani H. Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability. Biol Res. 2020;53(1):52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Korzyńska A, Zychowicz M. A method of estimation of the cell doubling time on basis of the cell culture monitoring data. Biocybern Biomed Eng. 2008;28(4):75–82.

    Google Scholar 

  15. Lukas J, Lukas C, Bartek J. Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time. DNA Repair. 2004;3(8–9):997–1007.

    Article  CAS  PubMed  Google Scholar 

  16. Hacker DL, De Jesus M, Wurm FM. 25 years of recombinant proteins from reactor-grown cells—where do we go from here? Biotechnol Adv. 2009;27(6):1023–7.

    Article  CAS  PubMed  Google Scholar 

  17. Borth N, Zeyda M, Kunert R, Katinger H. Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol Bioeng. 2000;71(4):266–73.

    Article  CAS  PubMed  Google Scholar 

  18. Kim JD, Yoon Y, Hwang HY, Park JS, Yu S, Lee J, et al. Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element. Biotechnol Prog. 2005;21(3):933–7.

    Article  CAS  PubMed  Google Scholar 

  19. Zarredar H, Pashapour S, Farajnia S, Ansarin K, Baradaran B, Ahmadzadeh V, et al. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: the effect of combining RNA interferences with a chemical inhibitor. J Cell Biochem. 2019;120(6):10670–7.

    Article  CAS  PubMed  Google Scholar 

  20. Safari F, Farajnia S, Ghasemi Y, Zarghami N. New developments in CRISPR technology: improvements in specificity and efficiency. Curr Pharm Biotechnol. 2017;18(13):1038–54.

    Article  CAS  PubMed  Google Scholar 

  21. Arden N, Betenbaugh MJ. Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends Biotechnol. 2004;22(4):174–80.

    Article  CAS  PubMed  Google Scholar 

  22. Kim NS, Lee GM. Overexpression of bcl-2 inhibits sodium butyrate-induced apoptosis in Chinese hamster ovary cells resulting in enhanced humanized antibody production. Biotechnol Bioeng. 2000;71(3):184–93.

    Article  CAS  PubMed  Google Scholar 

  23. Walsh JG, Cullen SP, Sheridan C, Lüthi AU, Gerner C, Martin SJ. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA. 2008;105(35):12815–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Julien O, Wells JA. Caspases and their substrates. Cell Death Differ. 2017;24(8):1380–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sung YH, Lee JS, Park SH, Koo J, Lee GM. Influence of co-down-regulation of caspase-3 and caspase-7 by siRNAs on sodium butyrate-induced apoptotic cell death of Chinese hamster ovary cells producing thrombopoietin. Metab Eng. 2007;9(5–6):452–64.

    Article  CAS  PubMed  Google Scholar 

  26. Kumar N, Gammell P, Clynes M. Proliferation control strategies to improve productivity and survival during CHO based production culture: a summary of recent methods employed and the effects of proliferation control in product secreting CHO cell lines. Cytotechnology. 2007;53(1–3):33–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Fischer U, Jänicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003;10(1):76–100.

    Article  CAS  PubMed  Google Scholar 

  28. Kim M, Murphy K, Liu F, Parker SE, Dowling ML, Baff W, et al. Caspase-mediated specific cleavage of BubR1 is a determinant of mitotic progression. Mol Cell Biol. 2005;25(21):9232–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Faragher AJ, Sun XM, Butterworth M, Harper N, Mulheran M, Ruchaud S, et al. Death receptor-induced apoptosis reveals a novel interplay between the chromosomal passenger complex and CENP-C during interphase. Mol Biol Cell. 2007;18(4):1337–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Misaghi S, Korbel GA, Kessler B, Spooner E, Ploegh HL. z-VAD-fmk inhibits peptide:N-glycanase and may result in ER stress. Cell Death Differ. 2006;13(1):163–5.

    Article  CAS  PubMed  Google Scholar 

  31. Musacchio A, Hardwick KG. The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol. 2002;3(10):731–41.

    Article  CAS  PubMed  Google Scholar 

  32. Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene. 2004;23(11):2016–27.

    Article  CAS  PubMed  Google Scholar 

  33. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432(7015):316–23.

    Article  CAS  PubMed  Google Scholar 

  34. Abaandou L, Sharma AK, Shiloach J. Knockout of the caspase 8-associated protein 2 gene improves recombinant protein expression in HEK293 cells through up-regulation of the cyclin-dependent kinase inhibitor 2A gene. Biotechnol Bioeng. 2021;118(1):186–98.

    Article  CAS  PubMed  Google Scholar 

  35. Du Z, Treiber D, McCarter JD, Fomina-Yadlin D, Saleem RA, McCoy RE, et al. Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures. Biotechnol Bioeng. 2015;112(1):141–55.

    Article  CAS  PubMed  Google Scholar 

  36. Hendrick V, Winnepenninckx P, Abdelkafi C, Vandeputte O, Cherlet M, Marique T, et al. Increased productivity of recombinant tissular plasminogen activator (t-PA) by butyrate and shift of temperature: a cell cycle phases analysis. Cytotechnology. 2001;36(1–3):71–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ibarra N, Watanabe S, Bi JX, Shuttleworth J, Al-Rubeai M. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells. Biotechnol Prog. 2003;19(1):224–8.

    Article  CAS  PubMed  Google Scholar 

  38. Bi JX, Shuttleworth J, Al-Rubeai M. Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnol Bioeng. 2004;85(7):741–9.

    Article  CAS  PubMed  Google Scholar 

  39. Carvalhal AV, Marcelino I, Carrondo MJ. Metabolic changes during cell growth inhibition by p27 overexpression. Appl Microbiol Biotechnol. 2003;63(2):164–73.

    Article  CAS  PubMed  Google Scholar 

  40. Dez C, Tollervey D. Ribosome synthesis meets the cell cycle. Curr Opin Microbiol. 2004;7(6):631–7.

    Article  CAS  PubMed  Google Scholar 

  41. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 1999;144(2):281–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Stennicke HR, Jürgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem. 1998;273(42):27084–90.

    Article  CAS  PubMed  Google Scholar 

  43. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997;272(29):17907–11.

    Article  CAS  PubMed  Google Scholar 

  44. Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, Mehal WZ, et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science (New York, NY). 2006;311(5762):847–51.

    Article  CAS  Google Scholar 

  45. Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson DW, et al. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med. 2000;6(11):1241–7.

    Article  CAS  PubMed  Google Scholar 

  46. Takahashi K, Kamiya K, Urase K, Suga M, Takizawa T, Mori H, et al. Caspase-3-deficiency induces hyperplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss. Brain Res. 2001;894(2):359–67.

    Article  CAS  PubMed  Google Scholar 

  47. Fallon AM, Hellestad VJ. Standardization of a colorimetric method to quantify growth and metabolic activity of Wolbachia-infected mosquito cells. In Vitro Cell Dev Biol Anim. 2008;44(8–9):351–6.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Traganos F. Flow cytometry: principles and applications. I. Cancer Investig. 1984;2(2):149–63.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors would like to thank the Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran for supporting this project.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Meshkinfam Ave, Shiraz, Iran

    Fatemeh Safari

  2. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Fatemeh Safari

  3. Department of Medical Biotechnology, School of Medical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Bahman Akbari

Authors
  1. Fatemeh Safari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bahman Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FS: the supervisor and main doer of the project who performed cell culture, transfection, and all assays, BA: he performed the statistical analysis. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Fatemeh Safari.

Ethics declarations

Ethics approval and consent to participate

Ethics approval for the study was obtained from an ethics committee of Tabriz University of Medical Sciences dated 2016/13/08, No: 5/4/46151.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Safari, F., Akbari, B. Knockout of caspase-7 gene improves the expression of recombinant protein in CHO cell line through the cell cycle arrest in G2/M phase. Biol Res 55, 2 (2022). https://doi.org/10.1186/s40659-021-00369-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40659-021-00369-9

Keywords

  • Caspase-7
  • Caspase-3
  • CRISPR/Cas9
  • Recombinant protein
  • Cell cycle
  • Chinese hamster ovary cell line

Biological Research

ISSN: 0717-6287

Contact us